Interacting Drugs |
Polysaccharide-iron complex, vitamin B12, and folic acid vs Bisphosphonate Derivatives |
Security Level |
 |
Mechanism |
Bisphosphonate Derivatives: Iron Salts may decrease the serum concentration of Bisphosphonate Derivatives. |
Management |
Avoid administration of oral iron supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate. Exceptions: Pamidronate; Zoledronic Acid. |
Polysaccharide-iron complex, vitamin B12, and folic acid vs Bisphosphonate Derivatives
Post Review about Polysaccharide-iron complex, vitamin B12, and folic acid vs Bisphosphonate Derivatives Click here to cancel reply.
Other Interactions of Polysaccharide-iron complex, vitamin B12, and folic acid
Other Interactions of Bisphosphonate Derivatives
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.